Frontlight ResearchEarly access
Trial site
Hachioji Diabetes Clinic
- 1running trial
- 3closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Type 1 diabetes2 trials
- Type 2 diabetes2 trials
- Obesity1 trial
- Phase
- Phase 34 trials
- Status
- Completed3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
Running trials
Closed trials
Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026